NASDAQ: FAMIFarmmi Inc Stock
$0.81-0.01 (-1.22%)
Updated Apr 17, 2024
FAMI Price
$0.81
Fair Value Price
N/A
Market Cap
$4.94M
52 Week Low
$0.77
52 Week High
$5.15
P/E
1.16x
P/B
0.03x
P/S
0.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$110.36M
Earnings
$2.54M
Gross Margin
3.9%
Operating Margin
3.18%
Profit Margin
2.3%
Debt to Equity
0.08
Operating Cash Flow
-$76M
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FAMI Overview
Farmmi, Inc., together with its subsidiaries, processes and sells agricultural products in China, the United States, Japan, Canada, Europe, Korea, and the Middle East. The company offers shiitake and Mu Er mushrooms; and other edible fungi products, including bamboo fungi, agrocybe aegerila, pleurotus eryngii, coprinus comatus, grifola frondosa, and hericium erinaceus. It also operates Farmmi Jicai, an online store that sells edible fungi products under Forasen and Farmmi Liangpin brands. In addition, the company processes dried mushroom and dried black fungus. It offers its products to restaurants, cafeterias, and local specialty stores, as well as through distributors. Farmmi, Inc. was incorporated in 2015 and is headquartered in Lishui, China.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FAMI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FAMI was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FAMI is good value based on its earnings relative to its share price (1.16x), compared to the US market average (41.64x)
P/E vs Market Valuation
FAMI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FAMI due diligence checks available for Premium users.
Be the first to know about important FAMI news, forecast changes, insider trades & much more!
FAMI News
Valuation
FAMI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
1.16x
Industry
8.38x
Market
41.64x
FAMI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FAMI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
FAMI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.03x
Industry
2.08x
FAMI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FAMI's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
FAMI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FAMI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$174.8M
Liabilities
$12.8M
Debt to equity
0.08
FAMI's short-term assets ($158.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FAMI's short-term assets ($158.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FAMI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FAMI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
FAMI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FAMI vs Food Stocks
Farmmi Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.